With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) and Keytruda, Merck & Co.’s partner Kelun-Biotech is the latest to claim that ...

CHENGDU, China, Nov. 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded ...

OptiTROP-Lung05 is a randomized, open-label, multicenter Phase III clinical study evaluating the efficacy and safety profile of sac-TMT in combination with pembrolizumab versus pembrolizumab ...

When attempting to create an interface VPC endpoint for the neptune-graph service using network-config.yaml, the pipeline fails at the Network_VPCs stage with an ...

One Piece: Into the Grand Line will be challenging Luffy and the Straw Hats with a major location and trial before actually getting into the Grand Line itself, and that means we’ll be seeing new ...

Because there was so much chatter about this launch, I was expecting it to hit a home run on its promises. I can happily confirm these leggings deliver exactly what’s expected: a camel toe-free ...

The green line issue on phones is a hardware problem that cannot be fixed by software. The display of the affected phone needs to be replaced, and depending on the phone model, such repair can ...

Securing your digital estate with endpoint detection and response (EDR) across all platforms, devices, and Internet of Things (IoT) has never been more challenging. A rapidly evolving cyberthreat ...

Sacituzumab govitecan-hziy significantly improved progression free survival over standard chemotherapy in untreated mTNBC patients ineligible for immunotherapy. Topline data were announced from a ...

Phase 2 (Actuate-1801 Part 3B) trial meets primary endpoint and demonstrates a clinically meaningful increase in median overall survival (10.1 months vs 7.2 months; log-rank p=0.01) in previously ...